Similar to our research, Choi et al. (Choi et al., 2020) built a group of five DEG markers, namely, BCL2, HER2, CD133, CAIX and ERCC1, which can be used to predict the response to chemotherapy and prognosis of cervical cancer. The gene discussed is ERBB2; the disease is cervical carcinoma.